Effect of Spironolactone on Expression of Angiotensin-converting Enzyme in Heart of Spontaneously Hypertensive Rats

CHENG Li,YANG Zhen,JIANG Wen-ping,MIAO Li-yan
DOI: https://doi.org/10.3969/j.issn.1673-0399.2008.03.013
2008-01-01
Abstract:Objective To compare the difference of angiotensin-converting enzyme(ACE) expression in heart between spontaneously hypertensive rats(SHR) and Wistar-Kyoto(WKY) rats,and to explore effects of spironolonctone on the ACE expression in SHR.Methods Sixteen-week-old male SHR and age-matched nomotensive WKY control rats were selected.SHR were randomly divided into placebo treated group,spironolactone treated group.The blood pressure(BP) was determinded by tailcuff.Four weeks after treatment,left ventricular weight was used to calculate left ventricular mass index(LVMI).Transcription-polyraerase chain reaction(RT-PCR) and Western blot were performed to detect the expression of ACE in myocardium in every group.Results(1) BP in SHR was significantly higher in WKY,spironolactone can reduce the level of BP gently.(2)LVMI was remarkable lower in WKY rats than in SHR,and LVMI in spironolactone-treated group was lower than that in the placebo-treated group.(3)Compare with WKY,ACE in myocardium of SHR was significant lower,spironolactone also can depress the expression of ACE.Conclusion Spironolactone can reduce the expression of ACE in myocardium in SHR,which may be the latent mechanism to reverse left ventricular hypertropy.
What problem does this paper attempt to address?